ClinicalTrials.Veeva

Menu

The Effect of Lifestyle Treatment in Patients With Morbid Obesity (LIFETIME)

S

Sykehuset i Vestfold HF

Status

Enrolling

Conditions

Leg Strength
Life of Quality
Eating Behavior
Physical Capacity

Treatments

Other: Lifestyle

Study type

Interventional

Funder types

Other

Identifiers

NCT03593148
LIFETIME

Details and patient eligibility

About

The effect of lifestyle treatment on physical capacity, maximal strength, eating behavior and quality of life in patients with morbid obesity (LIFETIME)

Full description

In this study, the investigators will investigate whether more intensive day-based lifestyle treatment process have a better effect on weight loss and health-related quality of life than a previous treatment. Investigators also want to investigate whether patients with good physical capacity (maximal oxygen uptake) and bone strength (maximum bone strength) before initiating treatment and / or after 3 and 6 months intensive training may have greater weight loss 1 and 2 years after treatment than patients with lower physical capacity and bone strength.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Treatment seeking morbidly obese patients (BMI ≥ 40 kg/m2 or BMI 35 to 39.9 kg/m2 with ≥ 1 co morbidity) attending the Vestfold Hospital Trust.

Exclusion criteria

  • Uncompensated heart failure
  • Recent myocardial infarction or stroke (<½ years)
  • Severe arrhythmia or heart failure
  • Unstable angina pectoris
  • Renal failure
  • Pregnancy
  • Severe eating disorders
  • Active substance abuse

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

600 participants in 1 patient group

Lifestyle treatment
Other group
Description:
Patients will be included in the Lifestyle treatment that is a existing treatment program at Vestfold Hospital Trust.
Treatment:
Other: Lifestyle

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jarle Berge; Jens Hertel, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems